Stephen C. Rubin, MD, Named Chief of Gynecologic Oncology at Fox Chase Cancer Center

March 6, 2014

PHILADELPHIA, PA (March 6, 2014)—Stephen C. Rubin, MD, has joined the Department of Surgical Oncology at Fox Chase Cancer Center as Chief of Gynecologic Oncology, where he will specialize in the treatment of patients with gynecologic cancers—including ovarian, uterine, cervical, and endometrial. Dr. Rubin has also been named Co-Clinical Leader of the Gynecological Service Line and Professor in the clinical investigator track of the Department of Surgical Oncology. In addition, he will hold the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology.

“Fox Chase has long been a national leader in research and treatment of women’s cancers, with special expertise in gynecological cancers,” says Richard I. Fisher, MD, President and CEO of Fox Chase. “The arrival of Dr. Rubin, a well recognized clinical leader in this field, strengthens the already excellent team in place and will open new avenues to improve the care we offer our patients even further.”

A nationally known expert in the management of ovarian cancer, Dr. Rubin's special interests include minimally invasive gynecologic surgery, hereditary ovarian cancer, and ovarian cancer clinical trials. Previously, he served as Chief of Gynecologic Oncology at the University of Pennsylvania School of Medicine and Health System and Director of the Gynecologic Oncology Research Program of Penn’s Abramson Cancer Center. Dr. Rubin also served as the Franklin Payne Chair in Gynecologic Oncology at the University of Pennsylvania School of Medicine, where he was a Professor of obstetrics and gynecology with tenure.

“I am absolutely delighted to be practicing at Fox Chase, the region’s only hospital devoted exclusively to cancer treatment, prevention, and research,” says Dr. Rubin. “Here, I can offer my patients the latest in cutting-edge care for gynecologic cancers and related conditions.”

Dr. Rubin received his medical degree from the University of Pennsylvania School of Medicine. He completed a residency in obstetrics and gynecology as well as a gynecologic oncology fellowship at the Hospital of the University of Pennsylvania.

Among his professional activities, Dr. Rubin is a member of numerous professional and scientific societies, including: the American College of Obstetricians and Gynecologists, American Gynecological and Obstetrical Society, Society of Gynecologic Oncologists, Society for Gynecologic Investigation, American College of Surgeons, American Society of Clinical Oncology, Society of Pelvic Surgeons, Philadelphia College of Physicians, Obstetrical Society of Philadelphia, and Mid-Atlantic Gynecologic Oncology Society.

Dr. Rubin has also served as an editor for some of the leading professional journals in his field, such as Gynecologic OncologyInternational Journal of Oncology, and Annals of Surgical Oncology.


The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).